Physician profile
David C You
NPI 1295892487
$4,504.59
in general payments reported to CMS, 2019-2025
34 companies · $1,598 in 2025
The $1,598 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $859 · 2020: $196 · 2021: $63.80 · 2022: $123 · 2023: $709 · 2024: $956 · 2025: $1,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,122 · Education: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,122.40 |
| Education | $140.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $942.69 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $620.54 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $545.01 | 2019-2025 | Ofev, Jascayd |
| Jazz Pharmaceuticals INC. | $428.85 | 2023-2025 | |
| Grifols USA, LLC | $251.11 | 2019-2025 | Prolastin-C Liquid |
| Avadel Cns Pharmaceuticals, LLC | $206.20 | 2023-2025 | Lumryz |
| Merck Sharp & Dohme LLC | $154.12 | 2019-2025 | Zerbaxa, Keytruda, Recarbrio |
| Genentech USA, INC. | $136.18 | 2019-2020 | |
| Inspire Medical Systems, INC. | $115.47 | 2024-2025 | Inspire |
| Mylan Specialty L.P. | $107.67 | 2024 | Yupelri |
| Insmed, INC. | $103.46 | 2019-2025 | Arikayce, Brinsupri |
| Philips North America LLC | $96.81 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Genzyme Corporation | $78.51 | 2023-2025 | |
| Ceribell, INC. | $74.46 | 2023-2024 | Pocket Eeg Device, Ceribell Rapid Response Eeg |
| Takeda Pharmaceuticals U.S.A., INC. | $69.62 | 2024-2025 | Glassia |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $62.67 | 2024-2025 | Zemaira, Veltassa |
| Baxter Healthcare | $54.01 | 2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Lilly USA, LLC | $48.42 | 2025 | Zepbound |
| Viatris Specialty LLC | $38.80 | 2025 | Yupelri |
| Axsome Therapeutics, INC. | $33.87 | 2025 | Sunosi |
| Vapotherm INC | $32.84 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $31.08 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $30.41 | 2019-2020 | |
| Pfizer INC. | $30.27 | 2023 | |
| Verona Pharma, INC. | $29.01 | 2025 | Ohtuvayre |
| Harmony Biosciences LLC | $25.41 | 2023 | Wakix |
| Inogen, INC. | $23.11 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Tactile Systems Technology INC | $22.12 | 2023 | Entre Plus, Flexitouch Plus |
| Shionogi INC | $20.77 | 2024 | Fetroja |
| Ani Pharmaceuticals, INC. | $20.42 | 2024 | Purified Cortrophin Gel |
| Alexion Pharmaceuticals, INC. | $19.70 | 2025 | Ultomiris |
| Electromed, INC. | $17.98 | 2024 | Smartvest |
| Pulmonx Corporation | $17.87 | 2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Shire North American Group INC | $15.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David You listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.